These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Opioids and neuropeptides: mechanisms in circulatory shock. Bernton EW; Long JB; Holaday JW Fed Proc; 1985 Feb; 44(2):290-9. PubMed ID: 3917942 [TBL] [Abstract][Full Text] [Related]
4. New pharmacologic approaches to spinal cord injury: opiate antagonists and thyrotropin-releasing hormone. Faden AI Cent Nerv Syst Trauma; 1985; 2(1):5-8. PubMed ID: 3004747 [No Abstract] [Full Text] [Related]
5. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone. Holaday JW Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678 [No Abstract] [Full Text] [Related]
6. The role of endogenous opiates in shock: experimental and clinical studies in vitro and in vivo. Weissglas IS Adv Shock Res; 1983; 10():87-94. PubMed ID: 6308977 [No Abstract] [Full Text] [Related]
7. Opiate antagonists and thyrotropin-releasing hormone. I. Potential role in the treatment of shock. Faden AI JAMA; 1984 Sep; 252(9):1177-80. PubMed ID: 6088820 [No Abstract] [Full Text] [Related]
8. Opiate antagonists in shock and trauma. Holaday JW Am J Emerg Med; 1984 Jan; 2(1):8-12. PubMed ID: 6097276 [TBL] [Abstract][Full Text] [Related]
12. A role for endorphins in the pathophysiology of spinal cord injury. Faden AI; Holaday JW Adv Biochem Psychopharmacol; 1981; 28():435-46. PubMed ID: 7211553 [TBL] [Abstract][Full Text] [Related]
13. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury. Faden AI Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771 [TBL] [Abstract][Full Text] [Related]
14. Endogenous opiates and the pathogenesis of hypertension. Szilagyi JE Clin Exp Hypertens A; 1989; 11(1):1-24. PubMed ID: 2653668 [TBL] [Abstract][Full Text] [Related]
15. Opiate antagonists and thyrotropin-releasing hormone. II. Potential role in the treatment of central nervous system injury. Faden AI JAMA; 1984 Sep; 252(11):1452-4. PubMed ID: 6433052 [No Abstract] [Full Text] [Related]
17. Endorphins in experimental spinal injury: therapeutic effect of naloxone. Faden AI; Jacobs TP; Mougey E; Holaday JW Ann Neurol; 1981 Oct; 10(4):326-32. PubMed ID: 6274252 [TBL] [Abstract][Full Text] [Related]
18. Endorphins in septic shock: hemodynamic and endocrine effects of an opiate receptor antagonist and agonist. Gahhos FN; Chiu RC; Hinchey EJ; Richards GK Arch Surg; 1982 Aug; 117(8):1053-7. PubMed ID: 6285853 [TBL] [Abstract][Full Text] [Related]
19. Effects of TRH in circulatory shock and central nervous system ischemia. Holaday JW; Long JB; Martinez-Arizala A; Chen HS; Reynolds DG; Gurll NJ Ann N Y Acad Sci; 1989; 553():370-9. PubMed ID: 2497680 [No Abstract] [Full Text] [Related]
20. Opiate antagonist in traumatic shock. McIntosh TK; Faden AI Ann Emerg Med; 1986 Dec; 15(12):1462-5. PubMed ID: 3022620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]